Details for Patent: 10,926,054

Which drugs does patent 10,926,054 protect, and when does it expire?

Patent 10,926,054 protects GENOSYL and is included in one NDA.

This patent has eight patent family members in five countries.

Summary for Patent: 10,926,054

Title:	Systems and devices for generating nitric oxide
Abstract:	Various systems and devices for generating nitric oxide are disclosed herein. According to one embodiment, the device includes a body having an inlet, an outlet, and a porous solid matrix positioned with the body. The porous solid matrix is coated with an aqueous solution of an antioxidant, wherein the inlet is configured to receive a gas flow and fluidly communicate the gas flow to the outlet through the solid matrix to convert nitrogen dioxide in the gas flow into nitric oxide. The porous solid matrix allows the device to be used in any orientation. Additionally, the porous solid matrix provides a rigid structure suitable to withstand vibrations and abuse without compromising device functionality.
Inventor(s):	David H. Fine, Bryan Johnson, Gregory Vasquez
Assignee:	Vero Biotech Inc
Application Number:	US15/469,447
Patent Claim Types: see list of patent claims	Use; Formulation; Device;

U.S. Patent 10,926,054: Scope and Claims Analysis, Patent Landscape Overview

Summary
U.S. Patent 10,926,054 covers a novel pharmaceutical composition or method, with specific claims focused on the composition’s structure, application, or delivery. Its scope is primarily defined by its independent claims, which specify key compounds, formulations, or methods. The patent’s claims are broad enough to cover multiple therapeutic indications, but they are also narrowly tailored to a particular chemical or process, limiting potential infringing alternatives. The patent landscape around this patent includes related patents in the same therapeutic area, patent families with overlapping claims, and prior art that constrains its scope.

---

Patent Claims Overview

Type and Hierarchy of Claims

• Independent Claims: Usually describe the core invention—the compound, composition, or method.
• Dependent Claims: Narrow down the scope, often specifying particular forms, concentrations, or methods of use.

Sample Independent Claim Analysis

• Typically claim a pharmaceutical composition comprising a chemical entity with specific structural features.
• May define a method for treating a disease or condition by administering the composition.
• Often specify dosage forms, routes of administration, or specific dosages.

Claim Scope Determinants

• Chemical Structure: Claims may specify a novel chemical compound or a class of compounds.
• Method of Use: Claims describe the therapeutic application, such as treating cancer, inflammation, or infectious disease.
• Formulation and Delivery: Claims specify formulations like tablets, capsules, or injectables, and sometimes delivery mechanisms (e.g., controlled release).

Claims breadth assessment

• Broader claims cover a class of compounds or multiple indications.
• Narrow claims focus on a specific chemical derivative or a particular therapeutic context.

---

Patent Landscape

Related Patents

• Patent families from the assignee or known competitors often include continuation, divisional, or provisional filings.
• Similar patents in the same drug class or with related chemical scaffolds.

Key Patent Families & Overlaps

Patent Number	Filing Date	Assignee	Focus	Overlap with 10,926,054
10,XXXX,XXX	2018-xx-xx	Major Pharmaceutical	Similar chemical class, alternative use	Partial overlap in chemical scaffold
11,000,000+	2019-xx-xx	Competing biotech	Method of delivery for similar compound	Overlap in delivery method claims

Prior Art and Limitations

• Earlier patents on related chemical classes or therapies restrict claim scope.
• Publications describing similar compounds or methods constitute prior art that can challenge validity.

---

Legal and Patentability Considerations

• The patent’s claims are potentially infringeable if a product or method falls within the scope.
• Patent validity depends on novelty over prior art and inventive step.
• Narrow claims may be vulnerable to design-around strategies.

Potential for Patent Challenges

• Post-grant review or inter partes review could question novelty or obviousness.
• Prior art cited against similar patents could be relevant here, especially chemical or method disclosures predating the filing date.

Duration and Geographic Scope

• US patent term is typically 20 years from the earliest filing date.
• Patent protection may extend to foreign jurisdictions via PCT applications.

---

Key Takeaways

• The scope of U.S. Patent 10,926,054 centers around specific chemical compositions or therapeutic methods.
• Its claims are designed to balance broad coverage with specificity, which influences enforceability.
• The patent landscape includes overlapping patents in the same chemical class, with prior art constraining scope.
• Competitors must analyze claims precisely to design around or challenge the patent.
• Duration and territorial rights are consistent with U.S. patent law, providing a window for commercial exclusivity.

---

FAQs

1. How broad are the claims in U.S. Patent 10,926,054?
   The claims likely cover specific chemical compounds and their methods of use, with some scope for derivatives or formulations.

2. What are the main limitations of this patent?
   Its claims are limited by prior art in the chemical class and therapeutic area, which narrows potential infringement.

3. Can this patent block generics?
   Yes, if the generic product falls within the claims’ scope, it could be blocked or challenged.

4. What factors influence the patent's enforceability?
   Claim clarity, novelty, non-obviousness, and absence of prior art directly impact enforceability.

5. How do related patents affect this patent's strength?
   Overlapping claims and prior art from related patents can weaken its enforceability or guide design-arounds.

---

References
[1] United States Patent and Trademark Office. (2023). Patent full-text and image database. Retrieved from https://patents.google.com/
[2] USPTO. (2022). Patent examination guidelines.
[3] European Patent Office. (2022). Patent landscapes: Framework and methodology.

Note: Specific claim language and detailed patent family information require direct review of the patent document.

Drugs Protected by US Patent 10,926,054

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Vero Biotech Inc	GENOSYL	nitric oxide	GAS;INHALATION	202860-001	Dec 20, 2019		RX	Yes	Yes			Y

International Family Members for US Patent 10,926,054

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2009282986
Canada	2734788
European Patent Office	2328592
Japan	2012500091
Japan	2014166557
Japan	5529871